Evidence map›Paper›PMID 42179806›Full record

ArticleKidney medicine2026

Kidney Transplant Complicated by Severe Parathyroid Hormone-Independent Hypercalcemia From Tumoral Calcinosis.

Abishek Volety, Nicholas Shaffer, Liam Biard, Timothy N Holbrook, Simran Demla, Angelito F Yango

Abstract readCase Reports
In one paragraph

Article in Kidney medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Abishek VoletyNephrology Division, Department of Medicine, University of Maryland Medical Center, Baltimore, MD.
Nicholas ShafferInternal Medicine, Baylor Scott & White All Saints Medical Center/Texas Christian University Medical School Graduate Medical Education, Fort Worth, TX.
Liam BiardInternal Medicine, Baylor Scott & White All Saints Medical Center/Texas Christian University Medical School Graduate Medical Education, Fort Worth, TX.
Timothy N HolbrookInternal Medicine, Baylor Scott & White All Saints Medical Center/Texas Christian University Medical School Graduate Medical Education, Fort Worth, TX.
Simran DemlaInternal Medicine, Baylor Scott & White All Saints Medical Center/Texas Christian University Medical School Graduate Medical Education, Fort Worth, TX.
Angelito F YangoClinical and Transplant Nephrology, Baylor Scott & White All Saints Medical Center, Fort Worth, TX.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumoral calcinosis (TC) is a rare complication of progressive kidney failure, characterized by massive depositions of calcium and phosphate into the periarticular soft tissue. Although generally associated with hyperparathyroidism and an elevated calcium-phosphorus product, there are few curative treatments for this condition. Although kidney transplantation typically leads to complete resolution of TC, the early posttransplant course may paradoxically mobilize soft tissue calcium into the general circulation, causing severe hypercalcemia and renal allograft injury. We report a rare case of acute allograft injury from severe hypercalcemia in a kidney transplant recipient, with worsening of her preexisting TC. The hypercalcemia was resistant to standard and off-label therapies, including saline, loop diuresis, calcimimetics, and bisphosphonates. Eventually, this was resolved with the initiation of temporary hemodialysis and saline infusion. This patient's severe pretransplant hyperparathyroidism, use of calcium-containing phosphate binders with activated vitamin D analogs, and prolonged dialysis dependence contributed to her unique clinical course. This case emphasizes the importance of individualized bone-mineral metabolism optimization in high-risk patients considered for kidney transplantation to prevent dangerous mineral shifts and preserve future allograft function.

Indexed as

dialysishypercalcemiahyperparathyroidismrenal transplantationTumoral calcinosis

Identifiers

PMID42179806
PMCPMC13195600

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.